AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2019
Nov 13, 2019
33298_dirs_2019-11-13_5229afc1-2a2e-4baa-af43-ce02b2fbccaa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2019-11-08
Reporting Person: Walters Happy David (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-08 | Common Stock, par value $0.01 | P | 51500 | $0.1860 | Acquired | 276500 | Direct |
| 2019-11-08 | Common Stock, par value $0.01 | P | 45500 | $0.1750 | Acquired | 322000 | Direct |
| 2019-11-08 | Common Stock, par value $0.01 | P | 38000 | $0.1840 | Acquired | 360000 | Direct |
| 2019-11-08 | Common Stock, par value $0.01 | P | 15200 | $0.1870 | Acquired | 375200 | Direct |
| 2019-11-08 | Common Stock, par value $0.01 | P | 15000 | $0.1700 | Acquired | 390200 | Direct |
| 2019-11-08 | Common Stock, par value $0.01 | P | 14800 | $0.1780 | Acquired | 405000 | Direct |
| 2019-11-08 | Common Stock, par value $0.01 | P | 10000 | $0.1740 | Acquired | 415000 | Direct |
| 2019-11-08 | Common Stock, par value $0.01 | P | 10000 | $0.1880 | Acquired | 425000 | Direct |
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17